On the public citation graph
Hepatoprotective effects of Erythrina abyssinica Lam Ex Dc against Non Alcoholic Fatty Liver Disease in Sprague Dawley Rats
0 signed · 56 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/dmrr.666openalex-snapshot
Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/path.4829openalex-snapshot
Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
inferredcites →https://doi.org/10.1007/s10620-005-1267-zopenalex-snapshot
Nonalcoholic Fatty Liver Disease: A Clinical Review
inferredcites →https://doi.org/10.1007/s11892-015-0607-4openalex-snapshot
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
inferredcites →https://doi.org/10.1016/b978-0-12-407766-9.00017-1openalex-snapshot
Protein Tyrosine Phosphatase 1B (PTP1B) and Obesity
inferredcites →https://doi.org/10.1016/j.amjms.2017.01.002openalex-snapshot
Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males
inferredcites →https://doi.org/10.1016/j.bmcl.2009.09.108openalex-snapshot
Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica
inferredcites →https://doi.org/10.1016/j.cgh.2017.12.001openalex-snapshot
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
inferredcites →https://doi.org/10.1016/j.cld.2015.10.011openalex-snapshot
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
inferredcites →https://doi.org/10.1016/j.dld.2018.01.126openalex-snapshot
From a fatty liver to a sugary blood
inferredcites →https://doi.org/10.1016/j.dld.2018.08.012openalex-snapshot
Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.jep.2007.06.011openalex-snapshot
Traditional dietary additives of the Maasai are antiviral against the measles virus
inferredcites →https://doi.org/10.1016/j.jhep.2014.10.023openalex-snapshot
NAFLD incidence and remission: Only a matter of weight gain and weight loss?
inferredcites →https://doi.org/10.1016/j.jhep.2014.12.012openalex-snapshot
NAFLD: A multisystem disease
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.013openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
inferredcites →https://doi.org/10.1016/j.jhep.2017.12.002openalex-snapshot
Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?
inferredcites →https://doi.org/10.1016/j.maturitas.2010.01.010openalex-snapshot
Flavonoids and age-related disease: Risk, benefits and critical windows
inferredcites →https://doi.org/10.1016/j.metabol.2015.12.012openalex-snapshot
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
inferredcites →https://doi.org/10.1016/j.phytochem.2004.08.050openalex-snapshot
Anti-plasmodial flavonoids from the stem bark of Erythrina abyssinica
inferredcites →https://doi.org/10.1016/s0022-2275(20)39047-7openalex-snapshot
The direct determination of liver triglycerides
inferredcites →https://doi.org/10.1016/s1572-5995(05)80070-5openalex-snapshot
Bioactive non-alkaloidal constituents from the genus Erythrina
inferredcites →https://doi.org/10.1021/np900745gopenalex-snapshot
AMP-Activated Protein Kinase (AMPK) Activation by Benzofurans and Coumestans Isolated from Erythrina abyssinica
inferredcites →https://doi.org/10.1053/jhep.2003.50161openalex-snapshot
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
inferredcites →https://doi.org/10.1055/a-0603-7899openalex-snapshot
The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1055/s-0032-1306423openalex-snapshot
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1097/meg.0000000000000408openalex-snapshot
Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones
inferredcites →https://doi.org/10.1111/apt.15087openalex-snapshot
Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density
inferredcites →https://doi.org/10.1111/j.1749-6632.1998.tb10603.xopenalex-snapshot
Effects of Monosodium Glutamate on Human Food Palatabilitya
inferredcites →https://doi.org/10.1111/j.1749-6632.2012.06511.xopenalex-snapshot
Flavonoids and metabolic syndrome
inferredcites →https://doi.org/10.1111/nyas.12016openalex-snapshot
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
inferredcites →https://doi.org/10.1136/postgradmedj-2018-135967openalex-snapshot
Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis
inferredcites →https://doi.org/10.1146/annurev-pathol-020117-043617openalex-snapshot
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1155/2011/351982openalex-snapshot
Rodent Models for Metabolic Syndrome Research
inferredcites →https://doi.org/10.1177/0023677216642398openalex-snapshot
Current concepts of Harm–Benefit Analysis of Animal Experiments – Report from the AALAS–FELASA Working Group on Harm–Benefit Analysis – Part 1
inferredcites →https://doi.org/10.1177/1557988318763631openalex-snapshot
Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients
inferredcites →https://doi.org/10.1186/1746-4269-10-24openalex-snapshot
A study of the medicinal plants used by the Marakwet Community in Kenya
inferredcites →https://doi.org/10.1186/s12876-018-0843-6openalex-snapshot
Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal
inferredcites →https://doi.org/10.1530/joe-14-0182openalex-snapshot
METABOLIC PHENOTYPING GUIDELINES: Assessing glucose homeostasis in rodent models
inferredcites →https://doi.org/10.2147/dmso.s43731openalex-snapshot
AMPK activation: a therapeutic target for type 2 diabetes?
inferredcites →https://doi.org/10.2174/0929867311320210001openalex-snapshot
Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
inferredcites →https://doi.org/10.2337/db13-0368openalex-snapshot
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
inferredcites →https://doi.org/10.2337/dc17-1902openalex-snapshot
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
inferredcites →https://doi.org/10.3109/13880209.2010.529615openalex-snapshot
Hypoglycemic activity ofErythrina variegataleaf in streptozotocin-induced diabetic rats
inferredcites →https://doi.org/10.3390/children4080074openalex-snapshot
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
inferredcites →https://doi.org/10.3390/diseases6040093openalex-snapshot
Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
inferredcites →https://doi.org/10.3390/nu10111571openalex-snapshot
Cafeteria Diet Feeding in Young Rats Leads to Hepatic Steatosis and Increased Gluconeogenesis under Fatty Acids and Glucagon Influence
inferredcites →https://doi.org/10.3748/wjg.v18.i19.2300openalex-snapshot
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.3791/52766openalex-snapshot
Sampling Blood from the Lateral Tail Vein of the Rat
inferredcites →https://doi.org/10.3892/ijmm.21.4.507openalex-snapshot
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.4103/2229-5070.113884openalex-snapshot
Ethics of involving animals in research
inferredcites →https://doi.org/10.4314/bcse.v23i2.44963openalex-snapshot
8-Methoxyneorautenol and radical scavenging flavonoids from Erythrina abyssinica
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1155/2021/5513484openalex-snapshot
Traditional Medicinal Uses, Phytoconstituents, Bioactivities, and Toxicities of Erythrina abyssinica Lam. ex DC. (Fabaceae): A Systematic Review
inferred← citeshttps://doi.org/10.21926/obm.icm.2503036openalex-snapshot
A Review on the Ethnomedicinal Plants Used in Zimbabwe for the Treatment and Management of Skin Conditions: Perspectives on Pharmacological and Toxicological Evaluation
inferred← citeshttps://doi.org/10.5772/intechopen.113291openalex-snapshot
Medicinal Plants Used for the Treatment and Management of Bilharziasis and Other Parasitic Infections Affecting Humans in Zimbabwe: A Systematic Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.